AOSSM’s continuing medical education program offers the highest quality sports medicine learning opportunities that promote positive change in the care of athletes.
2025 Annual Meeting Instructional Courses
Upcoming Deadlines
Submission Dates- September 20 – October 9, 2024
January 2025 – Final decisions sent
Types of Instructional Courses:
- Traditional Instructional Course
Traditional lecture style session with 2 moderators, 4-5 presenters and 15 minutes of discussion and Q&A time with the learners. - Case- Based Presentations
2 moderators with 4 – 8 panel members (Maximum of 10 faculty). Moderators present cases to the panel for discussion. The panel engages the learners to participate in the discussion. Moderators must allow for 15 minutes of Q&A with the learners.
- Biologics
- Elbow/Wrist/Hand
- Foot/ Ankle/ Leg
- Hip/Pelvis/Thigh
- Knee
- Knee/ACL
- Pediatrics
- Practice Management
- Prevention/Return to Play/ Sports Performance
- Shoulder
- Team Physician
Annual Meeting Abstract Submission
Upcoming Deadlines
Instructional Course Submission Opening Fall of 2024
Abstract Submission Now Closed
Thank you for your patience as we work to resolve technical issues with abstract submission. Co-authors now have until September 16, 2024 to complete disclosures. If you need assistance please email [email protected].
Guidelines
Abstract submission guidelines are also accessible through the AOSSM Abstract Center. Please review these guidelines prior to submitting.
Specialty Day Abstract Submission
Upcoming Deadlines
- Opens Monday, March 17, 2025
- Closes Monday, April 21, 2025
- Notification in August
Guidelines
Abstract submission guidelines are also accessible through the AOSSM Abstract Center. Please review these guidelines prior to submitting.
Journal Submission of Podium and Poster Presentations
All abstracts selected for podium or poster presentation must be submitted in manuscript form to one of the AOSSM journals: The American Journal of Sports Medicine, The Orthopaedic Journal of Sports Medicine, Sports Health, or The Video Journal of Sports Medicine. Abstracts previously published are not eligible for presentation at an AOSSM meeting. The submitted manuscript must be declined by an AOSSM journal before it can be submitted elsewhere. If one has already submitted a manuscript to an AOSSM journal and it has been accepted for publication, presenters are urged to communicate with journal staff and request that publication be deferred until after the AOSSM meeting in question. Staff will do their best to accommodate all such requests.
Policy for Violation of AOSSM first publication rights of Society research presentations.
When a violation of the publication requirement is discovered and confirmed, all the authors (including the authors of the annual Research Awards) involved shall be barred from having research of which they are authors presented at the next AOSSM Annual Meeting and next Specialty Day (podium or poster) for which abstract submission has not yet occurred.
All authors are held accountable.
All authors will also be barred for one year from submitting a manuscript for publication to any of the AOSSM journals.
Repeat offenders will bear the same consequences for five years of submission cycles each for the AOSSM Annual Meeting and AOSSM Specialty Day and five years at each of the journals.
Content Without Commercial Bias
The AOSSM must ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. It is an ACCME requirement that audiences at educational programs for which continuing medical education hours are awarded be informed of a presenter’s academic and professional affiliations, and the existence of any significant financial interest or other relationship an author or co-author has with the manufacturer(s) of any commercial product(s) or services. Any such relationship must be disclosed.
In accordance with ACCME standards, please note that the presenter of any accepted abstract cannot be employed by an ineligible company. Employees of ineligible companies are prohibited from having any role in the planning or implementation of CME activities related to the ineligible company’s business lines or products.